- Home
- LTRY vs ADXN Comparison
LTRY vs ADXN Comparison
Compare LTRY & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRY
- ADXN
- Stock Information
- Founded
- LTRY 2015
- ADXN 2002
- Country
- LTRY United States
- ADXN Switzerland
- Employees
- LTRY N/A
- ADXN N/A
- Industry
- LTRY Computer Software: Prepackaged Software
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- LTRY Technology
- ADXN Health Care
- Exchange
- LTRY Nasdaq
- ADXN Nasdaq
- Market Cap
- LTRY N/A
- ADXN 10.1M
- IPO Year
- LTRY N/A
- ADXN N/A
- Fundamental
- Price
- LTRY $1.31
- ADXN $9.36
- Analyst Decision
- LTRY
- ADXN Strong Buy
- Analyst Count
- LTRY 0
- ADXN 1
- Target Price
- LTRY N/A
- ADXN $30.00
- AVG Volume (30 Days)
- LTRY 1.1M
- ADXN 17.4K
- Earning Date
- LTRY 08-18-2025
- ADXN 08-11-2025
- Dividend Yield
- LTRY N/A
- ADXN N/A
- EPS Growth
- LTRY N/A
- ADXN N/A
- EPS
- LTRY N/A
- ADXN 0.10
- Revenue
- LTRY $1,030,318.00
- ADXN $278,508.00
- Revenue This Year
- LTRY N/A
- ADXN $86.57
- Revenue Next Year
- LTRY N/A
- ADXN N/A
- P/E Ratio
- LTRY N/A
- ADXN $0.76
- Revenue Growth
- LTRY N/A
- ADXN N/A
- 52 Week Low
- LTRY $0.22
- ADXN $6.51
- 52 Week High
- LTRY $2.65
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- LTRY 53.23
- ADXN 59.29
- Support Level
- LTRY $1.27
- ADXN $8.99
- Resistance Level
- LTRY $1.38
- ADXN $9.89
- Average True Range (ATR)
- LTRY 0.11
- ADXN 0.81
- MACD
- LTRY 0.01
- ADXN 0.06
- Stochastic Oscillator
- LTRY 77.14
- ADXN 78.07
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.